A quick DE thread, but I obviously have no idea really about the outcome of intense negotiations ahead. So just some auxiliary observations: 1) strong centrist vote - both AfD and Linke lose and are now de facto consigned to former East Germany with 75+% of vote in Center. 1/n
2) DE will now almost certainly have a 3-party coalition, as a new inverse GroKo with Scholz as Chancellor seem impossible to accept for CDU. This is a break from DE traditional very stable 2-party coalitions and likely heralds the end of very long chancellorships of 15+y 2/n
which will structurally weaken DE in Europe as the chancellor will no longer routinely be the longest ruling big country leader. 3) Coalition negotiations will be messy, as DE has no tradition of a single “royal investigator” at the time to scope out possible coalitions so 3/n
Instead everyone will negotiate with everyone else all the time, as there is no clear election winner. FDP and Greens to “decide” first among themselves who the next chancellor is would be unprecedented but possible. 4) It is clearly advantage SPD as Scholz ran an error free 4/n
Campaign and is widely preferred among voters as next chancellor. Laschet is the opposite, partly to blame for result and without a future in politics unless he becomes chancellor. This political weakness ironically makes him a better partner for Greens/FDP, as he is more 5/n
Likely to accept their demands and real question is if he can get CDU to accept. SPD has additional issue of having to have a member referendum on any coalition. 5) Voter movements indicate that CDU lost almost all votes to Greens and SPD and relatively few to FDP/AfD 6/n
making it electorally dangerous fir them to tag right in opposition = Merz as next leader would seem electoral suicide. 6) FDP gained little while both SPD and Greens gained 5+%, suggesting that FDP will be most keen on entering gov, as what else is purpose of party? Not 7/n
Clear that Lindner can ultimatively demand BMF as smallest party most keen on governing, and if so it is not selfevident that FinMin must represent DE in ECOFIN/EuroGroup. Greens might demand that say Habeck as “Econ/Environ super minister” does so. FDP will be junior party 8/n
In any coalition and must spend political capital wisely - not clear that just saying “no to Europe” would do. All to play for also in Europe in the coalition negotiations, even if FDP might prefer Jamaica and Green Ampel. 7) Everyone would like a quick coalition negotiation 9/n
But political uncertainty and possible counter proposals from “other main party” will dictate that it probably drags on for quite a while. Even forming governments in the Center takes time…. Just ask the Dutch/Belgians! END
Reaching very high levels of immunity from say 90% vaccination rates with more contagious virus variants in circulation seems the ultimate goal for vacc rollouts across the world. Good news is Europe - and UK especially - is reaching such levels for high priority groups now. A 🧵
1) Europe and the US are now facing the challenge of ensuring that up to 90% of also younger age groups ultimately gets vaccinated. Israel - a global frontrunner in vacc rollouts - offer important insights on how to nudge people less personally at risk of covid19 to get jabbed.
2) "The green-pass program worked—not because it proved one’s vaccination status and thereby enabled access to public places, but because it spurred the hesitant to get inoculated. And it worked." economist.com/by-invitation/…
An update; Vaccine news are improving across most of the EU as rollout accelerates. HU/MT now near US/UK levels, 3 laggards remains BG, LV and CR, while others roughly on par. Noticeably DE, ES and IT proceeding rapidly through EU vaccination rankings. A 🧵
2) A great communications gift meanwhile was given by @POTUS to the @EU_Commission this week, as US gov now hopes to "vaccinate 70% of adult Americans by July 4th". @vonderleyen could not have wished for more! apnews.com/article/corona…
3) @POTUS's new policy target is rhetorically similar enough to @vonderleyen's own goal of "having enough doses for vaccinating 70% of EU adults in July" to essentially signal to the EU publics and MS that the EU and US will "exit the pandemic together"
Time to talk global vaccine exports - a topic where data availability (hopefully) will soon improve as opportunities for "vaccine diplomacy" emerge and - despite the Indian tragedy and glaring global inequalities in vacc access, the news is generally quite good. A 🧵
2) Best news (H/T @ChadBown) is that @pfizer is now FINALLY starting to fulfill international contracts also from US located production, following the (alleged) expiry of de facto contractual bans on doing so. Up to 1mn doses now going to Mexico. 👍 reuters.com/business/healt…
3) EU exports continue to rise rapidly and reached - once the earliest shipments in Dec 2020-Jan 2021 are included in the data - ~161mn by late Apr with 148mn since Jan 31st 2021 alone bloomberg.com/news/articles/…
"We don't have enough to be confident to send it abroad"? This is absurd from @POTUS and US vaccine nationalism at its clearest. Consider what amount of vaccines the US has "on the shelves" now, what it has sent to others and what say the EU has done to date? 🧵
1) The US has per the @CDCgov a current unused stockpile of ~63mn FDA approved vacc doses (@Pfizer/ @moderna_tx / J&J), number that due to slowing vaccination rates as Americans who want it has already got it is rising at over 1mn/day.... covid.cdc.gov/covid-data-tra…
2) On top of that US medical experts estimate that the US now has 35-40mn non-FDA approved @AstraZeneca vaccines in storage, that it (given its focus on mRNA vaccines and AZ's side effects) is highly unlikely to ever use
Time to update the EU Covid vaccine charts. Situation is one of remarkable similarity across EU+NO+IS - with only HU (RU/CH vaccs) and MT (small size) well ahead of rest and BG, LV and CR materially lagging behind EU average. US (now ahead of UK) is well ahead of EU average. 1/n
The relative similarity of majority of EU MS' vacc levels is good news and indicates most MS are using essentially all the vaccines they receive now. Bodes well for ability to scale up as supplies increase. EU contrast to diff. vacc rates among US states is remarkable. 2/n
Focus on "elderly priority groups" highlights that UK program really, really well executed across old ages groups now for 1. jabs, but also that recent US "vacc surge" still leaves many elderly Americans behind, as some EU members have jabbed more elderly than the US 3/n
Time to update EU vaccination data; A clearer pic is emerging with MT and HU well ahead due to threshold and timing effect on vacc deliveries (MT) and RU/CH supply (HU), while BG, LV and CR lag behind EU average (Note - NL data a week old) 1/10
Apart from MT/HU at top and BG/LV/CR at bottom, rest of EU27+NO+IS increasingly clustering in the middle as some earlier frontrunners (DK/NO) suspend AZ vaccinations. This = best practices spreading and binding vacc supply (AZ overreliance?) constraints in BG/LV/CR. 2/10
A good news story is - despite it all - the acceleration in FR vaccinations, as gov appears to be using virtually all vaccs as they become available. Simple model suggests (if maintained) FR levels ~225k/day next 14days rising to ~385k/day after Apr 11 for rest of Apr 3/10